Robert Hettle
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
- CAR-T cell therapy research
- Pathology and Forensic Medicine top 10%
- Multiple Sclerosis Research Studies
Papers in
- Oncology 22
- PARP inhibition in cancer therapy 20
-
- Advanced Breast Cancer Therapies 13
- Co-authors
- Nerys Woolacott (1 shared paper)Mark Corbett (1 shared paper)Robert Hodgson (1 shared paper)Sebastian Hinde (1 shared paper)Stephen Palmer (1 shared paper)Julie Jones-Diette (1 shared paper)Mohd Kashif Siddiqui (2 shared papers)Xiaoyan Lu (2 shared papers)
- Journals
- Value in Health (12 papers)Journal of Clinical Oncology (6 papers)Annals of Oncology (5 papers)Gynecologic Oncology (3 papers)Cancer Research (3 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Robert Hettle
63 papers receiving 556 citations
Peers
Comparison fields: 5 of 56
- Oncology 213
- Pathology and Forensic Medicine 107
- Reproductive Medicine 35
- Infectious Diseases 56
- Pulmonary and Respiratory Medicine 70
Countries citing papers authored by Robert Hettle
This map shows the geographic impact of Robert Hettle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Hettle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Hettle more than expected).
Fields of papers citing papers by Robert Hettle
This network shows the impact of papers produced by Robert Hettle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Hettle. The network helps show where Robert Hettle may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Hettle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 104 | |
| 2 | 2017 | 67 | |
| 3 | 2019 | 58 | |
| 4 | 2015 | 39 | |
| 5 | 2018 | 31 | |
| 6 | 2012 | 22 | |
| 7 | 2021 | 18 | |
| 8 | 2017 | 16 | |
| 9 | 2020 | 16 | |
| 10 | 2011 | 14 | |
| 11 | 2017 | 10 | |
| 12 | 2015 | 10 | |
| 13 | 2021 | 9 | |
| 14 | 2019 | 9 | |
| 15 | 2020 | 9 | |
| 16 | 2023 | 8 | |
| 17 | 2021 | 8 | |
| 18 | 2015 | 8 | |
| 19 | 2020 | 7 | |
| 20 | 2018 | 7 |
About Robert Hettle
Robert Hettle is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Economics and Econometrics, Pathology and Forensic Medicine and Genetics, having authored 63 papers that have together received 563 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (20 papers), Advanced Breast Cancer Therapies (13 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers), Economic and Financial Impacts of Cancer (8 papers), BRCA gene mutations in cancer (7 papers), Tuberculosis Research and Epidemiology (5 papers), Advanced Causal Inference Techniques (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). The work is most often cited by research in Oncology (213 citations), Pathology and Forensic Medicine (107 citations), Reproductive Medicine (35 citations), Infectious Diseases (56 citations) and Pulmonary and Respiratory Medicine (70 citations). Robert Hettle has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Nerys Woolacott, Mark Corbett, Robert Hodgson, Sebastian Hinde, Stephen Palmer, Julie Jones-Diette, Mohd Kashif Siddiqui, Xiaoyan Lu, Anna N. Walker and Lara J. Wolfson. Their work appears in journals such as Value in Health, Journal of Clinical Oncology, Annals of Oncology, Gynecologic Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.